ASX Share rice
Thu 06 Aug 2020 - 03:13:am (Sydney)

PIQ Share Price

PROTEOMICS INTERNATIONAL LABORATORIES LTDPIQPharmaceuticals, Biotechnology & Life Sciences

PIQ Company Information

Name:

Proteomics International Laboratories Ltd

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Life Sciences Tools & Services

GIC Sub Industry:

Life Sciences Tools & Services

Address:

QEII Medical Centre Perth WA Australia 6009

Phone:

61 8 9389 1992

Co-Founder, MD & Director:

Dr. Richard John Lipscombe M.A., Ph.D., Ph.D., (London), MA (Oxford)

Head of Bus. Devel.:

Mr. John Chuck Morrison

Company Sec.:

Ms. Karen Teresa Logan B.Com., FCIS, BCom, DipAppCorpGov, FFin, ACIS, AGI

Company Overview:

Proteomics International Laboratories Ltd operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research, analytical, and consultancy. Proteomics International Laboratories Ltd has a research agreement with the Busselton Population Medical Research Institute to enhance diagnosis and treatment of lung conditions, such as asthma and chronic obstructive pulmonary disease; and the Janssen Research & Development, LLC for the research of diabetic kidney and heart disease treatment. The company was founded in 2001 and is based in Perth, Australia.

PIQ Share Price Information

Shares Issued:

91.88M

Market Capitalisation:

$62.94M

Revenue (TTM):

$2.76M

Revenue Per Share (TTM):

$0.03

Earnings per Share:

$-0.026

Profit Margin:

-0.5434

Operating Margin (TTM):

$-0.55

Return On Assets (TTM):

$-0.19

Return On Equity (TTM):

$-0.37

Quarterly Revenue Growth (YOY):

0.09

Gross Profit(TTM):

$1.88M

Diluted Earnings Per Share (TTM):

$-0.016

PIQ CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$890.41K

Change To Liabilities:

$-87,072

Total Cashflow From Investing Activities:

$890.41K

Net Borrowings:

$-147,500

Net Income:

$-2,080,275

Total Cash From Operating Activities:

$-1,667,009

Depreciation:

$188.29K

Change To Account Receivables:

$101.88K

Capital Expenditures:

$37.99K

PIQ Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-2,080,275

Net Income:

$-2,080,275

Gross Profit:

$1.47M

Operating Income:

$-3,070,051

Other Operating Expenses:

$669.54K

Interest Expense:

$27.06K

Total Revenue:

$1.47M

Total Operating Expenses:

$4.54M

Cost Of Revenue:

$810.40K

PIQ Balance Sheet

Balance Sheet Date:

2019-06-30

Intangible Assets:

$1.01K

Total Liabilities:

$634.59K

Total Stockholder Equity:

$2.99M

Other Current Liabilities:

$78.31K

Total Assets:

$3.62M

Common Stock:

$10.54M

Other Current Assets:

$1.19M

Retained Earnings:

$-8,263,972

Other Liabilities:

$67.18K

Other Assets:

$163.68K

Cash:

$1.51M

Total Current Liabilities:

$549.08K

Property - Plant & Equipment:

$213.68K

Net Tangible Assets:

$2.99M

Long-Term Investments:

$163.68K

Total Current Assets:

$3.24M

Net Receivables:

$464.92K

Short-Term Investments:

$378.37K

Accounts Payable:

$224.76K

Non Currrent Assets (Other):

$378.37K

Short-Term Investments:

$378.37

Non Current Liabilities Total:

$85.51K

PIQ Share Price History

PIQ News

04 May, 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
12 Dec, 2019
The simplest way to benefit from a rising market is to buy an index fund. When you buy individual stocks, you can make...
09 Oct, 2019
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...